IDiyas

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Christian Rommel

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 5.9

ph-index = 8

Forward Citations = 251(Granted Patents)


Location History:

  • Basel, CH (2019)
  • La Jolla, CA (US) (2012 - 2022)

Company Filing History:

goldMedal16 out of 34 
 
Intellikine LLC
 patents
silverMedal1 out of 15,458 
 
University of California
 patents
where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 11433065 - Certain chemical entities, compositions and methods (2022-09-06),
2. 10172858 - Combination pharmaceutical compositions and uses thereof (2019-01-08),
3. 9822131 - Certain chemical entities, compositions and methods (2017-11-21),
4. 9682141 - Combination of kinase inhibitors and uses thereof (2017-06-20),
5. 9669032 - Enhanced treatment regimens using mTOR inhibitors (2017-06-06),
6. 9655892 - Certain chemical entities, compositions and methods (2017-05-23),
7. 9629843 - MTOR modulators and uses thereof (2017-04-25),
8. 9522146 - Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof (2016-12-20),
9. 9295673 - Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof (2016-03-29),
10. 9216982 - Certain chemical entities, compositions and methods (2015-12-22),
11. 9206182 - Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof (2015-12-08),
12. 9174994 - Enhanced treatment regimens using mTor inhibitors (2015-11-03),
13. 8785456 - Substituted isoquinolin-1(2H)-ones, and methods of use thereof (2014-07-22),
14. 8703777 - Certain chemical entities, compositions and methods (2014-04-22),
15. 8569323 - Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof (2013-10-29),

Title: Inventor Spotlight: Christian Rommel

Introduction

Christian Rommel, a prominent inventor based in La Jolla, California, has made significant contributions to the field of pharmaceutical chemistry, boasting an impressive portfolio of 16 patents. His work primarily focuses on the development of chemical entities and compositions that target specific biological pathways, particularly those associated with proliferative disorders.

Latest Patents

Christian Rommel's latest patents include groundbreaking innovations in pharmaceutical compositions aimed at modulating PI3 kinase activity. His first patent describes certain chemical entities and methods for using these entities to treat diseases linked with PI3 kinase dysfunction. In another notable patent, he has developed combination pharmaceutical compositions that utilize synergistic effects of two cell-cycle suppressors for treating proliferative disorders. These innovations showcase his commitment to advancing medical treatments through chemical research.

Career Highlights

Throughout his career, Christian has collaborated with reputable organizations, including Intellikine LLC and the University of California. His role at these institutions has enabled him to bridge the gap between academic research and practical pharmaceutical applications, significantly impacting the industry.

Collaborations

In addition to his work with prominent institutions, Christian has had the opportunity to collaborate with notable colleagues, including Yi Liu and Pingda Ren. These partnerships reflect his collaborative approach to innovation, working with fellow experts to enhance the efficacy of his inventions.

Conclusion

Christian Rommel exemplifies the spirit of innovation in the pharmaceutical industry through his prolific patent portfolio and collaborative efforts. As he continues to develop new methods and compositions, his contributions are anticipated to influence the treatment of various diseases, highlighting the importance of ongoing research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…